Swedish Orphan Biovitrum AB (publ)
F:B6E
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Swedish Orphan Biovitrum AB (publ)
F:B6E
|
SE |
|
Central Pattana PCL
SET:CPN
|
TH |
|
Sands China Ltd
F:599A
|
MO |
Wall St Price Targets
B6E Price Targets Summary
Swedish Orphan Biovitrum AB (publ)
According to Wall Street analysts, the average 1-year price target for B6E is 30.69 EUR with a low forecast of 20.08 EUR and a high forecast of 37.28 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is B6E's stock price target?
Price Target
30.69
EUR
According to Wall Street analysts, the average 1-year price target for B6E is 30.69 EUR with a low forecast of 20.08 EUR and a high forecast of 37.28 EUR.
What is the Revenue forecast for Swedish Orphan Biovitrum AB (publ)?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Revenue has been 23%. The projected CAGR for the next 8 years is 9%.
What is the Gross Profit forecast for Swedish Orphan Biovitrum AB (publ)?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 27%. The projected CAGR for the next 8 years is 9%.
What is the Operating Income forecast for Swedish Orphan Biovitrum AB (publ)?
Projected CAGR
9%
The compound annual growth rate for Operating Income over the next 8 years is 9%.
What is the Pre-Tax Income forecast for Swedish Orphan Biovitrum AB (publ)?
Projected CAGR
600%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 600%.
What is the Net Income forecast for Swedish Orphan Biovitrum AB (publ)?
Projected CAGR
43%
The compound annual growth rate for Net Income over the next 8 years is 43%.
